Furthermore, Kari et al. demonstrated that in glioblastoma multiforme, electron transport chain complex III can bypass complex I to elevate intracellular ROS levels through G protein-coupled receptor 17 signaling, offering novel therapeutic implications [40]. The gene discussed is GPR17; the disease is glioblastoma.